Introduction

62
The Acinetobacter genus includes over 30 species, of which A. baumannii is the 63 most prevalent cause of nosocomial infections [1] , and A. lwoffii appears to be an emerging, 64 opportunistic pathogen [2] [3] [4] . Strains from both species often have an impressive number of 65 antibiotic-and toxin-resistance genes [1, [5] [6] [7] [8] [9] [10] . Infections due to these pathogens are 66 becoming increasingly difficult to treat [8] . With increasing rates of resistance in
67
Acinetobacter and other Gram-negative pathogens, there is an urgent need for new 68 approaches to therapeutics.
69
PPMOs are synthetic oligomers that mimic the structure of nucleic acid [11] . They 
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Methods
86
Bacteria. All strains of Acinetobacter were purchased from ATCC (Manassas, VA), except 87 A. baumannii AB0057, which was kindly provided by Todd Hoopman ( 
177
The results show that the viability of A. lwoffii increased slightly (3-fold) in the first 2 h 
270
This is in large part due to the inherent level of antibiotic resistance that many Acinetobacter 271 species and strains display, making treatment of these infections challenging [1, 4- 
292
Body temperature decreased less and survival increased with higher doses of (RXR) 4 -AcpP. Error bars indicate standard deviation.
